SCHEMBL8310072

SCHEMBL8310072

CC(=NOCCO)c1cncc(-c2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.46
PPARA Q07869 4/20 0.46
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MKNK1 Q9BUB5 2/20 0.39
MKNK2 Q9HBH9 2/20 0.39
CTSA P10619 2/20 0.38
KAT6A Q92794 1/20 0.38
MET P08581 1/20 0.37
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
XDH P47989 2/20 0.36
SCN2A Q99250 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8310069 1.00 PPARG (0.46) PPARGPPARALMNAMAPK1HTT
SCHEMBL8308303 0.84 PPARA (0.62) PPARGPPARALMNAMAPK1HTT
SCHEMBL8308305 0.84 PPARA (0.62) PPARGPPARALMNAMAPK1HTT
SCHEMBL5610798 0.82 LMNA (0.56) PPARGPPARALMNAMAPK1HTT
SCHEMBL5610797 0.82 LMNA (0.56) PPARGPPARALMNAMAPK1HTT
SCHEMBL8442117 0.80 MKNK1 (0.48) LMNAMAPK1HTTL3MBTL1MKNK1
SCHEMBL4476864 0.78 LMNA (0.69) PPARGPPARALMNAMAPK1HTT
SCHEMBL4476867 0.78 LMNA (0.69) PPARGPPARALMNAMAPK1HTT
SCHEMBL8304542 0.77 PPARG (0.54) PPARGPPARALMNAMAPK1HTT
SCHEMBL8304541 0.77 PPARG (0.54) PPARGPPARALMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed